CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-17 | BARASCH RICHARD A Director | Purchase | +10,000 | $0.55 | $6K | 217,193 |
| 2023-03-17 | BARASCH RICHARD A Director | Purchase | +52 | $0.55 | $29 | 217,245 |
| 2023-03-17 | BARASCH RICHARD A Director | Purchase | +200 | $0.55 | $110 | 217,445 |
| 2023-03-17 | BARASCH RICHARD A Director | Purchase | +9,948 | $0.55 | $5K | 227,393 |
| 2023-03-17 | BARASCH RICHARD A Director | Purchase | +7,654 | $0.55 | $4K | 235,047 |
| 2023-03-17 | BARASCH RICHARD A Director | Purchase | +2,146 | $0.55 | $1K | 237,193 |
| 2023-03-17 | BARASCH RICHARD A Director | Purchase | +10,000 | $0.55 | $6K | 247,193 |
| 2023-03-17 | BARASCH RICHARD A Director | Purchase | +10,000 | $0.55 | $6K | 257,193 |
| 2023-03-17 | Shah Mihir Chief Financial Officer | Grant or award | +176,191 | 226,914 | ||
| 2023-03-17 | Shah Mihir Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +440,477 | 440,477 | ||
| 2023-03-17 | Miller Matthew P Chief Operating Officer | Grant or award | +67,667 | 242,992 | ||
| 2023-03-17 | Miller Matthew P Chief Operating Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +169,169 | 169,169 | ||
| 2023-03-17 | SARIN RAVI YANG Director | Grant or award | +29,528 | 75,427 | ||
| 2023-03-17 | Virnich Daniel President | Grant or award | +114,944 | 738,529 | ||
| 2023-03-17 | Virnich Daniel President | Grant or award · Non-Qualified Stock Option (right to buy) | +287,361 | 287,361 | ||
| 2023-03-17 | O'Meara Maeve Director | Grant or award | +16,404 | 59,104 | ||
| 2023-03-17 | McGeorge Anne Director | Grant or award | +26,247 | 71,346 | ||
| 2023-03-17 | Pacala Mark L Director | Grant or award | +6,562 | 88,399 | ||
| 2023-03-17 | Johnson Karen Marie Director | Grant or award | +19,685 | 63,185 | ||
| 2023-03-17 | Hively Brad Chief Executive Officer | Grant or award | +168,512 | 724,182 |
Page 12 of 18 · 354 trades